Dehydroabietic acid

CAS No. 1740-19-8

Dehydroabietic acid( —— )

Catalog No. M18122 CAS No. 1740-19-8

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 59 In Stock
2MG 33 In Stock
5MG 52 In Stock
10MG 92 In Stock
25MG 174 In Stock
50MG 257 In Stock
100MG 369 In Stock
200MG Get Quote In Stock
500MG 871 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dehydroabietic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
  • Description
    Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EBV
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1740-19-8
  • Formula Weight
    300.44
  • Molecular Formula
    C20H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (332.85 mM)
  • SMILES
    CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD-3759

    A potent, oral active, BBB-penetrating EGFR inhibitor (IC50=7.2 nM, L858R pEGFR).

  • AZ7550 hydrochloride

    AZ7550 hydrochloride, an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).

  • Lapatinib

    A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.